|
Jul 25
|
20 Countries with the Highest Rates of Skin Cancer
|
|
Jul 25
|
Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 25
|
Merck is Safeguarding the Environment Through Green Chemistry
|
|
Jul 25
|
What Will be the Outcome of the Lawsuit Filed by Merck & Co. (MRK)?
|
|
Jul 25
|
12 Best Low Volatility Stocks to Buy Now
|
|
Jul 19
|
12 Highest Yielding Dow Jones Dividend Stocks
|
|
Jul 19
|
Merck Announces Phase 3 KEYNOTE-A18 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer
|
|
Jul 17
|
3 Ways Merck Supports the LGBTQ+ Community
|
|
Jul 13
|
15 Deadliest Cancers in the U.S.
|
|
Apr 28
|
UPDATE 1-US FDA panel backs restricted use of AstraZeneca's prostrate cancer drug
|
|
Apr 28
|
US FDA panel backs AstraZeneca's prostrate cancer drug
|
|
Apr 28
|
Update on FDA Advisory Committee Vote on LYNPARZA® (olaparib) Plus Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer
|
|
Apr 28
|
Merck (MRK) Q1 2023 Earnings Call Transcript
|
|
Apr 28
|
Pharma Stock Roundup: MRK & Others Post Q1 Results, LLY Drug Shines in Obesity Study
|
|
Apr 28
|
Company News for Apr 28, 2023
|
|
Apr 28
|
10 Best May Dividend Stocks To Buy
|
|
Apr 27
|
FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting
|
|
Apr 27
|
Merck (MRK) Beats on Q1 Earnings and Sales, Ups 2023 View
|
|
Apr 27
|
Why Merck Stock Is Trading Higher Today
|
|
Apr 27
|
Drugmakers brace for serious headwinds ahead
|